Related Experiment Video

Updated: Jun 5, 2026

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
06:36

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion

Published on: April 24, 2015

The FERM family proteins in cancer invasion and metastasis

Hefen Yu1, Yuxiang Zhang, Lin Ye

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Capital Medical University, Beijing, PR China. yhf23@ccmu.edu.cn

Frontiers in Bioscience (Landmark Edition)
|January 4, 2011
PubMed

Insights

FERM proteins, including ERM and Ehm2, are crucial in cancer metastasis by altering cell adhesion and cytoskeleton. Understanding their mechanisms offers new therapeutic targets for metastatic cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Metastasis is a primary cause of cancer-related mortality.
  • Cancer cells undergo significant molecular and cellular changes during metastasis.
  • FERM proteins play vital roles in cell adhesion, cytoskeleton organization, and signaling pathways.

Purpose of the Study:

  • To review the role and mechanisms of FERM proteins in cancer metastasis.
  • To highlight the specific involvement of ERM and Ehm2 proteins in this process.

Main Methods:

  • Literature review of studies on FERM proteins and cancer metastasis.
  • Analysis of signaling networks involving FERM proteins.

Main Results:

  • FERM proteins link transmembrane proteins to the cytoskeleton and anchor enzymatic activities to the plasma membrane.
  • These proteins are implicated in cell-extracellular matrix interactions, cell-cell communication, apoptosis, and carcinogenesis.
  • ERM and Ehm2 proteins are specifically discussed in the context of their contribution to metastasis.

Conclusions:

  • FERM proteins are critical regulators of cellular processes essential for cancer metastasis.
  • Targeting FERM proteins, particularly ERM and Ehm2, may offer novel therapeutic strategies against metastatic cancer.

More Related Videos

Modeling and Imaging 3-Dimensional Collective Cell Invasion07:08

Modeling and Imaging 3-Dimensional Collective Cell Invasion

Published on: December 7, 2011

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...